FI105401B - Menetelmä terapeuttisesti käyttökelpoisten 1-(1-fenyylisykloalkyyli)substituoitujen 7-hydroksi-2-alkyyli-1,2,3,4-tetrahydroisokinoliiniyhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 1-(1-fenyylisykloalkyyli)substituoitujen 7-hydroksi-2-alkyyli-1,2,3,4-tetrahydroisokinoliiniyhdisteiden valmistamiseksi Download PDF

Info

Publication number
FI105401B
FI105401B FI943018A FI943018A FI105401B FI 105401 B FI105401 B FI 105401B FI 943018 A FI943018 A FI 943018A FI 943018 A FI943018 A FI 943018A FI 105401 B FI105401 B FI 105401B
Authority
FI
Finland
Prior art keywords
mixture
formula
ether
methyl
residue
Prior art date
Application number
FI943018A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943018A (fi
FI943018A0 (fi
Inventor
Antonin Kozlik
Bruce Jeremy Sargent
Patricia Lesley Needman
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of FI943018A publication Critical patent/FI943018A/fi
Publication of FI943018A0 publication Critical patent/FI943018A0/fi
Application granted granted Critical
Publication of FI105401B publication Critical patent/FI105401B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943018A 1991-12-23 1994-06-22 Menetelmä terapeuttisesti käyttökelpoisten 1-(1-fenyylisykloalkyyli)substituoitujen 7-hydroksi-2-alkyyli-1,2,3,4-tetrahydroisokinoliiniyhdisteiden valmistamiseksi FI105401B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9127306 1991-12-23
GB919127306A GB9127306D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
EP9202900 1992-12-12
PCT/EP1992/002900 WO1993013073A1 (en) 1991-12-23 1992-12-12 Substituted tetrahydroisoquinolines and their use as therapeutic agents
CN93109559A CN1045291C (zh) 1991-12-23 1993-06-26 制备被取代的四氢异喹啉化合物的方法
CN93109559 1993-06-26

Publications (3)

Publication Number Publication Date
FI943018A FI943018A (fi) 1994-06-22
FI943018A0 FI943018A0 (fi) 1994-06-22
FI105401B true FI105401B (fi) 2000-08-15

Family

ID=36822306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943018A FI105401B (fi) 1991-12-23 1994-06-22 Menetelmä terapeuttisesti käyttökelpoisten 1-(1-fenyylisykloalkyyli)substituoitujen 7-hydroksi-2-alkyyli-1,2,3,4-tetrahydroisokinoliiniyhdisteiden valmistamiseksi

Country Status (28)

Country Link
US (1) US5519034A (de)
EP (1) EP0618900B1 (de)
JP (1) JP2642244B2 (de)
CN (1) CN1045291C (de)
AT (1) ATE150015T1 (de)
AU (1) AU662584B2 (de)
BG (1) BG62326B1 (de)
CA (1) CA2126308A1 (de)
CZ (1) CZ282869B6 (de)
DE (1) DE69218248T2 (de)
DK (1) DK0618900T3 (de)
ES (1) ES2098721T3 (de)
FI (1) FI105401B (de)
GB (1) GB9127306D0 (de)
GR (1) GR3023568T3 (de)
HR (1) HRP921458B1 (de)
HU (2) HUT70495A (de)
IL (1) IL104170A (de)
IN (1) IN174437B (de)
MX (1) MX9207495A (de)
NO (1) NO301474B1 (de)
NZ (1) NZ246155A (de)
PL (1) PL173944B1 (de)
RO (1) RO114790B1 (de)
RU (1) RU2122999C1 (de)
SI (1) SI9200410B (de)
SK (1) SK280318B6 (de)
WO (1) WO1993013073A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK280108B6 (sk) * 1993-06-22 1999-08-06 Knoll Aktiengesellschaft Tetraizochinolínové deriváty, farmaceutické prostr
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
DK0832069T3 (da) * 1995-06-07 2003-04-22 Pfizer Biphenyl-2-carboxylsyre-tetrahydroisoquinolin-6-ylamidderivater, deres fremstilling og deres anvendelse som inhibitorer af sekretion af mikrosomalt triglyceridoverførselsprotein og/eller apolipoprotein B (Apo B)
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
AU2176597A (en) * 1996-03-29 1997-10-22 Lederle (Japan), Ltd. Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain
WO1999016752A1 (en) * 1997-09-30 1999-04-08 Molecular Designs International, Inc. β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USING
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
US5919794A (en) * 1998-05-11 1999-07-06 Virginia Commonwealth University Methods of using pharmaceutical tetrahydroisoquinolines
GB0012214D0 (en) * 2000-05-19 2000-07-12 Merck Sharp & Dohme Therapeutic agents
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
WO2003007959A1 (en) * 2001-07-16 2003-01-30 Fujisawa Pharmaceutical Co., Ltd. Quinoxaline derivatives which have parp inhibitory action
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
EP1426049B1 (de) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
JP2008518910A (ja) * 2004-11-04 2008-06-05 マリンクロッド・インコーポレイテッド オピエート中間体および合成方法
US7622586B2 (en) * 2005-10-21 2009-11-24 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
US7511060B2 (en) 2005-10-21 2009-03-31 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
CN102083797B (zh) * 2008-04-01 2014-06-04 Abbvie公司 四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途
US20090312558A1 (en) * 2008-06-13 2009-12-17 Reliance Life Sciences Pvt. Ltd. Process for the preparation of arylcyclopropoane carboxylic carbonitriles, and compounds derived therefrom
AR075442A1 (es) 2009-02-16 2011-03-30 Abbott Gmbh & Co Kg Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
US8846743B2 (en) 2010-08-13 2014-09-30 Abbott Laboratories Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en) 2010-08-13 2015-06-09 AbbVie Deutschland GmbH & Co. KG Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en) 2010-08-13 2015-06-02 AbbVie Deutschland GmbH & Co. KG Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en) 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en) 2010-08-13 2014-11-11 Abbott Laboratories Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en) 2011-05-12 2016-04-12 AbbVie Deutschland GmbH & Co. KG Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
EP2739614B1 (de) 2011-08-05 2017-02-22 AbbVie Deutschland GmbH & Co KG Aminochromanderivate, pharmazeutische zusammensetzungen davon und ihre therapeutische verwendung
CN104011028A (zh) 2011-11-18 2014-08-27 艾伯维德国有限责任两合公司 N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途
US9365512B2 (en) 2012-02-13 2016-06-14 AbbVie Deutschland GmbH & Co. KG Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
EP2872145B8 (de) 2012-07-12 2022-04-13 Emalex Biosciences, Inc. Kondensierte benzazepine zur behandlung des tourette-syndroms
US9650334B2 (en) 2013-03-15 2017-05-16 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en) 2013-03-15 2017-05-23 Abbvie Inc. Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
JP6153179B2 (ja) * 2013-04-02 2017-06-28 アンジー ファーマスーティカル シーオー.,エルティーディー.Annji Pharmaceutical Co., Ltd. 抗神経変性剤としての多機能キノリン誘導体
CN103435545B (zh) * 2013-08-14 2015-10-07 中国药科大学 四氢异喹啉季铵盐类衍生物、其制备方法及其镇痛用途
SG11201602982YA (en) 2013-10-17 2016-05-30 Abbvie Deutschland Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
EP3057958B1 (de) 2013-10-17 2019-05-01 AbbVie Deutschland GmbH & Co. KG Aminotetralin- und aminoindanderivate, pharmazeutische zusammensetzungen damit und deren verwendung in der therapie
RS60556B1 (sr) 2013-10-18 2020-08-31 Emalex Biosciences Inc Kondenzovani benzazepini za lečenje mucanja
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
TWI815829B (zh) 2017-11-14 2023-09-21 美商默沙東有限責任公司 作為吲哚胺2,3-二氧酶(ido)抑制劑之新穎經取代二芳基化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR868733A (fr) * 1939-10-14 1942-01-14 Troponwerke Dinklage & Co Procédé pour la fabrication des composés d'isoquinoleine
US3717639A (en) * 1967-05-04 1973-02-20 Little Inc A Process for the preparation of 1-(2-nitro-3,4-di-lower-alkoxybenzyl)isoquinolines
US3755330A (en) * 1967-08-25 1973-08-28 Sandoz Ag 1-{60 -hydroxybenzyl 3-methyl, 1,2,3,4-tetrahydroiso quinolino-2-carbonitriles
JPS4933805B1 (de) * 1969-01-31 1974-09-10
US3852448A (en) * 1971-02-04 1974-12-03 Sandoz Ag N-substituted amino-n-nitroso-aminoacetonitriles for treating hypertension
US3872130A (en) * 1971-09-27 1975-03-18 Mead Johnson & Co 1-hydroxyisoquinolones
US3777026A (en) * 1972-06-14 1973-12-04 Sandoz Ag N-substituted amino-n-nitroso-amino-acetonitriles as anti-anginal agents
US4013664A (en) * 1973-06-20 1977-03-22 Research Corporation Synthesis of hernandaline
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
US4126615A (en) * 1975-12-12 1978-11-21 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt Process for the manufacture of pure isoquinoline derivatives
US4194044A (en) * 1976-12-06 1980-03-18 Hoffmann-La Roche Inc. Process for preparing 3-phenoxy morphinans
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
US4514569A (en) * 1982-01-28 1985-04-30 Hendrickson James B Synthesis of 1-substituted isoquinolines
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
DK8386A (da) * 1986-01-15 1987-07-09 Tpo Pharmachim Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
US4737504A (en) * 1986-07-25 1988-04-12 Ohio State University Research Foundation 5-fluoro-and 8-fluoro-trimetoquinol compounds and the processes for their preparation
US4915879A (en) * 1986-09-19 1990-04-10 Automatic Liquid Packaging, Inc. Signal coupling for humidifier container
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein

Also Published As

Publication number Publication date
DE69218248D1 (de) 1997-04-17
SI9200410A (en) 1993-09-30
FI943018A (fi) 1994-06-22
RU2122999C1 (ru) 1998-12-10
SK75194A3 (en) 1995-08-09
IL104170A (en) 1999-04-11
CA2126308A1 (en) 1993-07-08
HRP921458A2 (en) 1995-06-30
NO301474B1 (no) 1997-11-03
IL104170A0 (en) 1993-05-13
NO942375D0 (de) 1994-06-22
BG98822A (bg) 1995-05-31
JP2642244B2 (ja) 1997-08-20
ATE150015T1 (de) 1997-03-15
CN1096780A (zh) 1994-12-28
DK0618900T3 (da) 1997-04-07
CZ153494A3 (en) 1995-07-12
NZ246155A (en) 1996-02-27
HU9401878D0 (en) 1994-09-28
PL173944B1 (pl) 1998-05-29
AU662584B2 (en) 1995-09-07
CN1045291C (zh) 1999-09-29
HRP921458B1 (en) 1999-02-28
WO1993013073A1 (en) 1993-07-08
AU3158693A (en) 1993-07-28
SI9200410B (sl) 2002-02-28
DE69218248T2 (de) 1997-06-19
HU211302A9 (en) 1995-11-28
GB9127306D0 (en) 1992-02-19
HUT70495A (en) 1995-10-30
CZ282869B6 (cs) 1997-11-12
RO114790B1 (ro) 1999-07-30
BG62326B1 (bg) 1999-08-31
ES2098721T3 (es) 1997-05-01
RU94030499A (ru) 1996-04-20
MX9207495A (es) 1993-07-01
NO942375L (no) 1994-06-22
US5519034A (en) 1996-05-21
IN174437B (de) 1994-12-03
JPH07502279A (ja) 1995-03-09
EP0618900A1 (de) 1994-10-12
SK280318B6 (sk) 1999-11-08
FI943018A0 (fi) 1994-06-22
EP0618900B1 (de) 1997-03-12
GR3023568T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
FI105401B (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-(1-fenyylisykloalkyyli)substituoitujen 7-hydroksi-2-alkyyli-1,2,3,4-tetrahydroisokinoliiniyhdisteiden valmistamiseksi
De Paulis et al. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H] spiperone binding of 3, 5-disubstituted N-[(1-ethyl-2-pyrrolidinyl) methyl]-6-methoxysalicylamides
JPH07316113A (ja) 新規アリールアルキル(チオ)アミド化合物
JPH0552309B2 (de)
Reitsema A Novel Rearrangement of a Piperidine Ring
JPS6221343B2 (de)
RU2232753C2 (ru) 4-замещенные пиперидины, фармацевтическая композиция на их основе и способ лечения заболеваний центральной нервной системы
CA1224491A (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives
BE854655A (fr) 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese
JPS60185749A (ja) アラルキル(アリ−ルエチニル)アラルキルアミン類および血管拡張剤および抗高血圧剤としてのそれらの使用
CA2871961A1 (en) Method for the preparation of 1-aryl-1-alkyl-2-alkyl-3-dialkylaminopropane compounds
Ikeda et al. Photochemical synthesis of 1, 2, 3, 4-tetrahydroisoquinolin-3-ones from N-chloroacetylbenzylamines
JP4108977B2 (ja) 新規化合物
FI82926C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara fenetylaminderivat.
KR100248558B1 (ko) 치환된 테트라하이드로이소퀴놀린, 이의 제조방법 및 이를 포함하는 약제학적 조성물
IE43132B1 (en) Cis-bicyclooctyl-alkyl-amine derivatives
Bailey et al. Local anesthetics derived from quinoline and isoquinoline
US3127405A (en) I-phenylalkyl
SMITH JR The Synthesis of 3-benzazepines
PL97350B1 (pl) Sposob wytwarzania nowych pochodnych dziesieciowodoroizochinoliny
BE724993A (de)
CH326015A (fr) Procédé de préparation de nouvelles amines
JPH03178953A (ja) 置換フェニルアセトアミド
CS244675B2 (cs) Způsob výroby (1 -arylcyklobutyllalkylaminů